Disease/Infection News

RSS

New clinical trial to assess antiretroviral treatment in HIV-infected individuals based on CD4 counts

A major new clinical trial seeks to determine whether HIV-infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later, based on their level of CD4+ T-cells.

8 Mar 2011

UTHealth study: Children with H. pylori infection have lower levels of iron

Children without previous iron deficiencies or anemia who remained infected with Helicobacter pylori had significantly lower levels of iron compared to children who had the infection eradicated, according to researchers at The University of Texas Health Science Center at Houston.

8 Mar 2011

Scientists sequence Clostridium botulinum genome that produces neurotoxin

Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.

8 Mar 2011

Excelsior medical's SwabFlush receives FDA 510(k) clearance

Excelsior Medical Corporation announced today that it has received FDA 510(k) clearance for SwabFlush™, its latest product for the vascular access and infection control markets.

8 Mar 2011

NanoLogix announces MRSA testing preliminary results, new Science Advisory Board members at UTHSC

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell microorganisms, announces preliminary results of MRSA testing at the University of Texas Health Science Center - Houston. Dr. Jonathan Faro, M.D., Ph.D. has found NanoLogix technology is able to deliver results for MRSA in 6 hours, as opposed to conventional culture-based testing wait times of 24 to 48 hours.

7 Mar 2011

Food safety lawyer calls on DeFranco & Sons to pay medical bills for hazelnuts victims

Food safety lawyer Fred Pritzker is calling on DeFranco & Sons, a Los Angeles, California wholesaler to pay medical bills and other costs incurred by victims of the multi-state E. coli O157:H7 outbreak associated with eating in-the-shell hazelnuts, also known as filberts.

6 Mar 2011

New research: Rectal specific microbicides can protect against HIV

Microbicides can be used to protect against HIV, and other sexually transmitted diseases, either on their own or with the added protection of a condom. New research published by BioMed Central's open access journal AIDS Research and Therapy has investigated the use of lubricants, originally designed for vaginal application, and has developed and tested new, rectal specific, formulations.

6 Mar 2011

Rotary International, Itzhak Perlman join Chicago Symphony Orchestra to present Concert to End Polio

Rotary International, violin virtuoso Itzhak Perlman and guest conductor James DePreist join members of the Chicago Symphony Orchestra to present the Concert to End Polio to benefit the global effort to eradicate this disabling childhood disease.

5 Mar 2011

iPrEx update, bone mineral density study highlighted at day three of 18th CROI

The 18th Conference on Retroviruses and Opportunistic Infections is being held at the Hynes Convention Center in Boston from February 27 through March 2. Day three of this major HIV/AIDS research conference included the following selected presentations from scientists supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

5 Mar 2011

U.N. panel recommends reparations fund for victims of sexual violence in DRC

A high-level U.N. panel on Thursday recommended that the international community "create a special reparations fund for victims of sexual violence in the Democratic Republic of Congo," following an assessment of the conditions faced by survivors of such acts, Agence France-Presse reports.

5 Mar 2011

HIV prevention, treatment highlighted at Conference on Retroviruses and Opportunistic Infections

Today was the last day of the 18th Conference on Retroviruses and Opportunistic Infections, a key HIV/AIDS research meeting being held at the Hynes Convention Center in Boston from February 27 through March 2. Highlighted below are selected presentations from March 2nd on research supported by the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, both components of the National Institutes of Health.

5 Mar 2011

American Express, TakePart announce final round of Members Project winners

American Express and TakePart announced today the final round of Members Project winners, chosen by the public through online voting. These five organizations will collectively receive $1 million in funding from American Express to advance their missions of serving communities around the country.

5 Mar 2011

Grifols receives FDA approval for Alphanate to treat vCJD

Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.

5 Mar 2011

Recent releases in Global Health

The Importance Of Investing In Adolescent Girls: A Lancet editorial examines the challenges adolescent girls living in developing countries face and the work of the U.N. Adolescent Girls Task Force to help young women overcome these barriers.

5 Mar 2011

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.

5 Mar 2011

IMMY, University of Nevada, Reno collaborate to make new blood test for Cryptococcosis

A new, rapid blood test that could lead to early diagnosis and potentially save the lives of hundreds of thousands of people stricken with fungal meningitis, a leading cause of AIDS-related deaths in developing countries, is getting closer to market with a recent collaboration between the University of Nevada, Reno and Immuno-Mycologics in Oklahoma.

5 Mar 2011

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Sangamo BioSciences, Inc. announced that data from its programs to develop ZFN-based therapeutic approaches for the treatment of HIV/AIDS were discussed in four oral presentations at the 18th Conference on Retroviruses and Opportunistic Infections, held in Boston from February 27 to March 2, 2011.

4 Mar 2011

New study suggests HIV-positive people aren't paranoid

People in marginalized groups, such as the disabled or racial minorities, feel stigmatized-condemned, feared, or excluded-when other people stigmatize them. That's obvious. But they can also feel stigma when nobody blatantly discriminates against them or says a negative word.

4 Mar 2011

Study: Vaccinated children and adolescents are less prone to infectious diseases

May vaccinations put too much strain on or weaken children's immune systems and are therefore harmful? Roma Schmitz and her colleagues from the Robert Koch Institute investigate exactly this research question in the current issue of Deutsches Ärzteblatt International.

4 Mar 2011

Pediatrician unveils latest findings of IMPAACT HIV/AIDS study during 2011 CROI

A clinical study of anti-HIV/AIDS medicines in the developing world is on the verge of turning "the whole treatment world on its head," according to Dartmouth pediatrician Paul Palumbo.

4 Mar 2011

Disease/Infection News

New clinical trial to assess antiretroviral treatment in HIV-infected individuals based on CD4 counts

UTHealth study: Children with H. pylori infection have lower levels of iron

Scientists sequence Clostridium botulinum genome that produces neurotoxin

Excelsior medical's SwabFlush receives FDA 510(k) clearance

NanoLogix announces MRSA testing preliminary results, new Science Advisory Board members at UTHSC

Food safety lawyer calls on DeFranco & Sons to pay medical bills for hazelnuts victims

New research: Rectal specific microbicides can protect against HIV

Rotary International, Itzhak Perlman join Chicago Symphony Orchestra to present Concert to End Polio

iPrEx update, bone mineral density study highlighted at day three of 18th CROI

U.N. panel recommends reparations fund for victims of sexual violence in DRC

HIV prevention, treatment highlighted at Conference on Retroviruses and Opportunistic Infections

American Express, TakePart announce final round of Members Project winners

Grifols receives FDA approval for Alphanate to treat vCJD

Recent releases in Global Health

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

IMMY, University of Nevada, Reno collaborate to make new blood test for Cryptococcosis

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

New study suggests HIV-positive people aren't paranoid

Study: Vaccinated children and adolescents are less prone to infectious diseases

Pediatrician unveils latest findings of IMPAACT HIV/AIDS study during 2011 CROI

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News